The malignant pediatric brain tumor medulloblastoma is driven by proteins deep within the cancer cells, for which there are often no effective drugs available. Researchers at Uppsala University have identified a new genetic technique that enables targeting of tumor cells with elevated levels of such proteins. The technique could be used to eliminate cells responsible for tumor relapse. The hope is to develop an effective drug against recurrence of this disease within a few years.
This article was originally published on MedicalXpress.com
